Resolvin D1 mitigates energy metabolism disorder after ischemia-reperfusion of the rat lung

Journal of Translational Medicine

Volumn 14, Issue 1, 2016, Pages

  Zhao, Qifeng ^a   Wu, Ji ^b   Hua, Qingwang ^a   Lin, Zhiyong ^a   Ye, Leping ^a   Zhang, Weixi ^a   Wu, Guowei ^a   Du, Jie ^a   Xia, Jie ^a   Chu, Maoping ^a   Hu, Xingti ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Wuhan Medical and Healthcare Center for Woman and Children   (China)

Author keywords

Energy metabolism; Inflammatory factor; Lung ischemia reperfusion injury; Oxidative stress; Resolvin

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; GLUTATHIONE PEROXIDASE; GLYCOGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; LACTIC ACID; LIPOXIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; MALONALDEHYDE; MONOCYTE CHEMOTACTIC PROTEIN 1; RESOLVIN D1; SUPEROXIDE DISMUTASE; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DOCOSAHEXAENOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; INFLAMMATION; LUNG INJURY; LUNG ISCHEMIA REPERFUSION INJURY; MALE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; RAT; REPERFUSION INJURY; ULTRASTRUCTURE; ANIMAL; COMPLICATION; DRUG EFFECTS; LUNG; LUNG FUNCTION TEST; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; APOPTOSIS; DOCOSAHEXAENOIC ACIDS; ENERGY METABOLISM; INFLAMMATION; LUNG; LUNG INJURY; MALE; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RESPIRATORY FUNCTION TESTS;

EID: 84962022370     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-016-0835-7     Document Type: Article

References (61)

1. Ng CS, Wan S, Yim AP, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest. 2002;121:1269-77.
2. Adiego CS, Gonzalez-Casaurran G, Perea LA, Vina JI, Ameigeiras EV, Martin CG, et al. Experimental swine lung autotransplant model to study lung ischemia-reperfusion injury. Arch Bronconeumol. 2011;47:283-9.
3. Langer F, Schramm R, Bauer M, Tscholl D, Kunihara T, Schafers HJ. Cytokine response to pulmonary thromboendarterectomy. Chest. 2004;126:135-41.
4. Weinbroum AA, Hochhauser E, Rudick V, Kluger Y, Karchevsky E, Graf E, et al. Multiple organ dysfunction after remote circulatory arrest: common pathway of radical oxygen species? J Trauma. 1999;47:691-8.
5. Olguner C, Koca U, Kar A, Karci A, Islekel H, Canyilmaz M, et al. Ischemic preconditioning attenuates the lipid peroxidation and remote lung injury in the rat model of unilateral lower limb ischemia reperfusion. Acta Anaesthesiol Scand. 2006;50:150-5.
6. van der Kaaij NP, Kluin J, Haitsma JJ, den Bakker MA, Lambrecht BN, Lachmann B, et al. Ischemia of the lung causes extensive long-term pulmonary injury: an experimental study. Respir Res. 2008;9:28.
7. Lopaschuk G. Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J. 2000;139:S115-9.
8. Inci I, Dutly A, Rousson V, Boehler A, Weder W. Trimetazidine protects the energy status after ischemia and reduces reperfusion injury in a rat single lung transplant model. J Thorac Cardiovasc Surg. 2001;122:1155-61.
9. Hyvarinen J, Hassinen IE, Sormunen R, Maki JM, Kivirikko KI, Koivunen P, et al. Hearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injury. J Biol Chem. 2010;285:13646-57.
10. Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr. 2012;32:203-27.
11. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8:349-61.
12. Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92-101.
13. Kasuga K, Yang R, Porter TF, Agrawal N, Petasis NA, Irimia D, et al. Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. J Immunol. 2008;181:8677-87.
14. Keyes KT, Ye Y, Lin Y, Zhang C, Perez-Polo JR, Gjorstrup P, et al. Resolvin E1 protects the rat heart against reperfusion injury. Am J Physiol Heart Circ Physiol. 2010;299:H153-64.
15. Gobbetti T, Le Faouder P, Bertrand J, Dubourdeau M, Barocelli E, Cenac N, et al. Polyunsaturated fatty acid metabolism signature in ischemia differs from reperfusion in mouse intestine. PLoS One. 2013;8:e75581.
16. Gilbert K, Bernier J, Godbout R, Rousseau G. Resolvin D1, a metabolite of omega-3 polyunsaturated fatty acid, decreases post-myocardial infarct depression. Mar Drugs. 2014;12:5396-407.
17. Zhao Q, Shao L, Hu X, Wu G, Du J, Xia J, et al. Lipoxin a4 preconditioning and postconditioning protect myocardial ischemia/reperfusion injury in rats. Mediators Inflamm. 2013;2013:231351.
18. Wu L, Miao S, Zou LB, Wu P, Hao H, Tang K, et al. Lipoxin A4 inhibits 5-lipoxygenase translocation and leukotrienes biosynthesis to exert a neuroprotective effect in cerebral ischemia/reperfusion injury. J Mol Neurosci. 2012;48:185-200.
19. Zhao Q, Hu X, Shao L, Wu G, Du J, Xia J. LipoxinA4 attenuates myocardial ischemia reperfusion injury via a mechanism related to downregulation of GRP-78 and caspase-12 in rats. Heart Vessels. 2014;29:667-78.
20. Wang Q, Zheng X, Cheng Y, Zhang YL, Wen HX, Tao Z, et al. Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na, K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury. J Immunol. 2014;192:3765-77.
21. Wang L, Yuan R, Yao C, Wu Q, Christelle M, Xie W, et al. Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice. Chin Med J. 2014;127:803-9.
22. Altunkaya A, Oz E, Sivrikoz MC, Halit V, Yener N, Erdogan D, et al. Role of the nitric oxide pathway in ischemia-reperfusion injury in isolated perfused guinea pig lungs. Mol Cell Biochem. 2006;290:9-16.
23. Chen F, Date H. Update on ischemia-reperfusion injury in lung transplantation. Curr Opin Organ Transplant. 2015;20:515-20.
24. Cottini SR, Lerch N, de Perrot M, Treggiari MM, Spiliopoulos A, Nicod L, Ricou B. Risk factors for reperfusion injury after lung transplantation. Intensive Care Med. 2006;32:557-63.
25. Jiang L, Li L, Shen J, Qi Z, Guo L. Effect of dexmedetomidine on lung ischemia-reperfusion injury. Mol Med Rep. 2014;9(2):419-26.
26. Hsu HH, Wu SY, Tang SE, Wu GC, Li MH, Huang KL, et al. Protection against reperfusion lung injury via aborgating multiple signaling cascades by trichostatin A. Int Immunopharmacol. 2015;25:267-75.
27. Forgiarini LF, Forgiarini LA Jr, da Rosa DP, Silva MB, Mariano R, Paludo Ade O, et al. N-acetylcysteine administration confers lung protection in different phases of lung ischaemia-reperfusion injury. Interact CardioVasc Thorac Surg. 2014;19:894-9.
28. Zhu B, Yang JR, Chen SF, Jiang YQ. The attenuation of lung ischemia reperfusion injury by oxymatrine. Cell Biochem Biophys. 2014;70:333-6.
29. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med. 2003;167:490-511.
30. Ilhan N, Halifeoglu I, Ozercan HI, Ilhan N. Tissue malondialdehyde and adenosine triphosphatase level after experimental liver ischaemia-reperfusion damage. Cell Biochem Funct. 2001;19:207-12.
31. van Hoorn EC, van Middelaar-Voskuilen MC, van Limpt CJ, Lamb KJ, Bouritius H, Vriesema AJ, et al. Preoperative supplementation with a carbohydrate mixture decreases organ dysfunction-associated risk factors. Clin Nutr. 2005;24:114-23.
32. Dona M, Fredman G, Schwab JM, Chiang N, Arita M, Goodarzi A, et al. Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and platelets. Blood. 2008;112:848-55.
33. Navarro-Xavier RA, Newson J, Silveira VL, Farrow SN, Gilroy DW, Bystrom J. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J Immunol. 2010;184:1516-25.
34. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007;447:869-74.
35. Jin Y, Arita M, Zhang Q, Saban DR, Chauhan SK, Chiang N, et al. Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. Invest Ophthalmol Vis Sci. 2009;50:4743-52.
36. Eady TN, Khoutorova L, Anzola DV, Hong SH, Obenaus A, Mohd-Yusof A, et al. Acute treatment with docosahexaenoic acid complexed to albumin reduces injury after a permanent focal cerebral ischemia in rats. PLoS ONE. 2013;8:e77237.
37. Fehrenbach H, Tews S, Fehrenbach A, Ochs M, Wittwer T, Wahlers T, et al. Improved lung preservation relates to an increase in tubular myelin-associated surfactant protein A. Respir Res. 2005;6:60.
38. Valino F, Casals C, Guerrero R, Alvarez L, Santos M, Saenz A, et al. Inhaled nitric oxide affects endogenous surfactant in experimental lung transplantation. Transplantation. 2004;77:812-8.
39. Cox R Jr, Phillips O, Fukumoto J, Fukumoto I, Parthasarathy PT, Arias S, et al. Enhanced resolution of hyperoxic acute lung injury as a result of aspirin triggered resolvin D1 treatment. Am J Respir Cell Mol Biol. 2015;53(3):422-35.
40. Xie W, Wang H, Wang L, Yao C, Yuan R, Wu Q. Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO-1 in LPS-induced mice. Lab Invest. 2013;93(9):991-1000.
41. Hirata T, Fukuse T, Nakamura T, Ueda M, Kawashima M, Hitomi S, et al. Reperfusion lung injury after cold preservation correlates with decreased levels of intrapulmonary high-energy phosphates. Transplantation. 2000;69:1793-801.
42. Dhein S, Grassl M, Gerdom M, Vollroth M, Bakhtiary F, von Salisch S, et al. Organ-protective effects on the liver and kidney by minocycline in small piglets undergoing cardiopulonary bypass. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:663-76.
43. +-ATPase cell surface abundance by simulated ischemia-reperfusion and ouabain preconditioning. Am J Physiol Heart Circ Physiol. 2013;304:H94-103.
44. Guo HC, Guo F, Zhang LN, Zhang R, Chen Q, Li JX, et al. Enhancement of Na/K pump activity by chronic intermittent hypobaric hypoxia protected against reperfusion injury. Am J Physiol Heart Circ Physiol. 2011;300:H2280-7.
45. Van Emous JG, Vleggeert-Lankamp CL, Nederhoff MG, Ruigrok TJ, Van Echteld CJ. Postischemic Na(+)-K(+)-ATPase reactivation is delayed in the absence of glycolytic ATP in isolated rat hearts. Am J Physiol Heart Circ Physiol. 2001;280:H2189-95.
46. +-ATPase inhibition in cardiomyocytes. Can J Physiol Pharmacol. 2010;88:702-15.
47. Li DB, Zhao CL, Lin HY, Li XH, Wu YC. Effects of astragalus and angelica injections on adenosine triphosphate-ase in renal injury induced by ischemia/reperfusion in rabbits. Chin J Clin Rehabil. 2005;9(15):222-4.
48. Chong ZZ, Xu QP, Sun JN. Effects and mechanisms of triacetylshikimic acid on platelet adhesion to neutrophils induced by thrombin and reperfusion after focal cerebral ischemia in rats. Acta Pharmacol Sin. 2001;22(8):679-84.
49. Sukoyan GV, Kavadze IK. Effect of nadcin on energy supply system and apoptosis in ischemia-reperfusion injury to the myocardium. Bull Exp Biol Med. 2008;46(3):321-4.
50. Ying W. NAD + and NADH in brain functions, brain diseases and brain aging. Front Bioscience J Virtual libr. 2007;12:1863-88.
51. Ito K, Shimada J, Kato D, Toda S, Takagi T, Naito Y, et al. Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-gamma ligand, on lung ischemia-reperfusion injury in rats. Eur J Cardiothorac Surg Off J Eur Assoc Cardio thorac Surg. 2004;25:530-6.
52. Naidu BV, Farivar AS, Woolley SM, Grainger D, Verrier ED, Mulligan MS. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2004;23:128-34.
53. Wang L, Yuan R, Yao C, Wu Q, Christelle M, Xie W, et al. Effects of resolvin D1 on inflammatory responses and oxidative stress of lipopolysaccharide-induced acute lung injury in mice. Chin Med J. 2014;127:803-9.
54. Woolley SM, Farivar AS, Naidu BV, Salzman A, Szabo C, Thomas R, et al. Role of poly (ADP) ribose synthetase in lung ischemia-reperfusion injury. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2004;23:1290-6.
55. Ruiz-Gines JA, Lopez-Ongil S, Gonzalez-Rubio M, Gonzalez-Santiago L, Rodriguez-Puyol M, Rodriguez-Puyol D. Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J Cardiovasc Pharmacol. 2000;35:109-13.
56. Urso ML, Clarkson PM. Oxidative stress, exercise, and antioxidant supplementation. Toxicology. 2003;189:41-54.
57. Li YW, Zhang Y, Zhang L, Li X, Yu JB, Zhang HT, et al. Protective effect of tea polyphenols on renal ischemia/reperfusion injury via suppressing the activation of TLR4/NF-kappaB p65 signal pathway. Gene. 2014;542:46-51.
58. Bongard RD, Yan K, Hoffmann RG, Audi SH, Zhang X, Lindemer BJ, et al. Depleted energy charge and increased pulmonary endothelial permeability induced by mitochondrial complex I inhibition are mitigated by coenzyme Q1 in the isolated perfused rat lung. Free Radic Biol Med. 2013;65:1455-63.
59. Choi YS, Cho KO, Kim EJ, Sung KW, Kim SY. Ischemic preconditioning in the rat hippocampus increases antioxidant activities but does not affect the level of hydroxyl radicals during subsequent severe ischemia. Exp Mol Med. 2007;39:556-63.
60. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000;190:255-66.
61. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev. 2003;17:2481-95.